12-121921483-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144668.6(CFAP251):c.178G>A(p.Glu60Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000249 in 1,607,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144668.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP251 | NM_144668.6 | c.178G>A | p.Glu60Lys | missense_variant | 2/22 | ENST00000288912.9 | NP_653269.3 | |
CFAP251 | NM_001178003.2 | c.178G>A | p.Glu60Lys | missense_variant | 2/18 | NP_001171474.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP251 | ENST00000288912.9 | c.178G>A | p.Glu60Lys | missense_variant | 2/22 | 1 | NM_144668.6 | ENSP00000288912 | ||
CFAP251 | ENST00000397454.2 | c.178G>A | p.Glu60Lys | missense_variant | 2/18 | 1 | ENSP00000380595 | P1 | ||
CFAP251 | ENST00000540779.1 | n.76G>A | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000685 AC: 1AN: 145948Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000168 AC: 4AN: 237556Hom.: 0 AF XY: 0.0000155 AC XY: 2AN XY: 129178
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461154Hom.: 0 Cov.: 61 AF XY: 0.00000275 AC XY: 2AN XY: 726852
GnomAD4 genome AF: 0.00000685 AC: 1AN: 145948Hom.: 0 Cov.: 33 AF XY: 0.0000141 AC XY: 1AN XY: 70938
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.178G>A (p.E60K) alteration is located in exon 2 (coding exon 1) of the WDR66 gene. This alteration results from a G to A substitution at nucleotide position 178, causing the glutamic acid (E) at amino acid position 60 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at